Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-20

Clinical Trial Update: Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing radiotherapy alone versus radiotherapy plus temozolomide in high-risk low-grade gliomas after surgery is currently recruiting (Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temozolomide (Temozolomide)

Snippet

Sponsor: West China Hospital | Conditions: Low-grade Glioma | Phase 2, Phase 3 | Status: RECRUITING